Antibiotics are a category of antimicrobials used in the treatment and prevention of bacterial infections. They may inhibit or kill the growth of bacteria. Many antibiotics are also effective against protozoans and fungi; some are toxic to animals and humans also, even when given in therapeutic dosage. Antibiotics are not effective against viruses such as influenza or a common cold, and maybe harmful when taken inappropriately. Hilaris Conferences on Antibiotics: Discovery & Development 2020 provides the chance to discuss quite innovations in Antibiotics such as the inclusion of Conventional and Non-Conventional Strategies to Fight Resistant Bacteria.
Antibiotic is one of the most essential commercially oppressed secondary metabolites produced by bacteria, fungi, and Streptomyces and employed in a wide range. Most of the antibiotics used today are from the microorganisms that live in the soil. Bacteria are easy to isolate, culture, maintain and improve their strain. The main producers of the microbial metabolites, the actinobacteria, fungi, and other filamentous bacteria, represent inexhaustible sources for the future.
Antibiotics are used economically, potentially useful in medicine for activities other than their antimicrobial action. They are used as antitumor agents, enzyme inhibitors along with powerful hypocholesterolemic agents, immunosuppressive agents, and anti-migraine agents, etc. This session mainly is to focus on the application of antibacterial, antifungals, and anti-cancers with their clinical use to date, including the development history, side effects, and etc. The antibiotics were divided by their uses, structure types, and molecular mechanisms.
Hilaris Conferences is the way to find out innovations and will be the platform to execute your skill to achieve targets. Diverse and innovative Conferences with a plethora of research topics will provide everyone a unique learning and career-building opportunities. Hilaris Conferences will sharp your brain with new and innovative ideas which will help you to boost yourself and confidence.
As research into antibiotic resistance expands, it is crucial to adopt an explicitly proactive approach to antibiotic resistance identification and surveillance, as well as antibiotic therapy development. So we need a broad spectrum of study and research, in all relevant areas of Antibiotics, Antibiotic Resistance, Infection Diseases, Drug Discovery, Pharmaceuticals, Antimicrobials, Antimicrobial Resistance.
Why to attend:
Hilaris Conferences on Antibiotics: Discovery & Development 2020 is the world stage for presenting researches with reference to antibiotics, infections and exchanging ideas, contributes to the dissemination of information in Antibiotics & Antimicrobials for the advantage for both the academic and business.
Target Audience:
- Food Safety Experts
- Alliances of antibiotics
- Business Entrepreneurs
- Antibiotics Researchers
- Strategic Drug Development
- Executive Council of Global
- Directors of Pharma Industries
- Medical Affairs and Networking
- Public Health Preparedness Sectors
- Scientific Business Communications
- Antibiotics Associations & Societies
- Professors
- Associate Professors
- Medical companies
- Pharmaceutical companies
- Entrepreneurs
- Researchers
- Scientists
- Commercialization
The global antibiotics market was valued at USD 42,653.89 million in 2018 and is estimated to be valued at USD 56,369.92 million in 2024, witnessing a CAGR of 4.7%. Certain factors that are driving the market growth include the emergence of anti-MRSA drugs, development of generic drugs, and vulnerable aging population. This can be mainly associated with the growing incidences of infectious diseases such as pneumonia, HIV/AIDS, malaria, and tuberculosis along with technological advancements that are expected to become the most common growth factors globally in the coming years.
Related Associations and Societies:
- World Health Organization
- U.S. Food and Drug Administration (FDA)
- Natural Resources Defense Council (NRDC)
- Infectious Diseases Society of America
- World Health Assembly
- Center for a Livable Future (CLF)
- The Humane Society of the United States (HSUS)
- Alliance for the Prudent Use of Antibiotics
- Civil Society Organizations
- British Society for Antimicrobial Chemotherapy
- Pediatric Infectious Diseases Society
- Royal Society of Medicine
- European Society of Clinical Microbiology and Infectious Diseases
- CAESAR (Central Asian & Eastern European Surveillance of Antimicrobial Resistance)
- WAAAR - World Alliance Against Antibiotic Resistance
- ReAct – Action on Antibiotic Resistance
- American Medical Association
Related Companies:
- Gilead Sciences
- Pfizer
- Abbott Laboratories
- Merck & Co
- Eli Lilly
- Astellas Pharma
- Teva Pharmaceutical Industries
- Boehringer Ingelheim
- Roche
- Mylan
- 3-D Matrix
- Agilent
- BeiGene
- BioDuro
- Fosun Pharma
